Gsk (GSK) Equity Average (2016 - 2025)
Gsk (GSK) has 6 years of Equity Average data on record, last reported at $17.1 billion in Q4 2024.
- For Q4 2024, Equity Average rose 17.64% year-over-year to $17.1 billion; the TTM value through Dec 2024 reached $17.1 billion, up 17.64%, while the annual FY2024 figure was $17.0 billion, 14.67% up from the prior year.
- Equity Average reached $17.1 billion in Q4 2024 per GSK's latest filing, up from $14.5 billion in the prior quarter.
- Across five years, Equity Average topped out at $17.1 billion in Q4 2024 and bottomed at $14.5 billion in Q4 2023.
- Average Equity Average over 3 years is $16.0 billion, with a median of $16.4 billion recorded in 2022.
- Peak YoY movement for Equity Average: dropped 11.39% in 2023, then increased 17.64% in 2024.
- A 3-year view of Equity Average shows it stood at $16.4 billion in 2022, then dropped by 11.39% to $14.5 billion in 2023, then increased by 17.64% to $17.1 billion in 2024.
- Per Business Quant database, its latest 3 readings for Equity Average were $17.1 billion in Q4 2024, $14.5 billion in Q4 2023, and $16.4 billion in Q4 2022.